Online citations, reference lists, and bibliographies.
← Back to Search

Reversion Of Multidrug Resistance By Co-encapsulation Of Doxorubicin And Cyclosporin A In Polyalkylcyanoacrylate Nanoparticles.

C. E. Soma, C. Dubernet, D. Bentolila, S. Benita, P. Couvreur
Published 2000 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Individual and combined polyalkylcyanoacrylate nanoparticle formulation of cyclosporin A and doxorubicin were prepared and evaluated in an attempt to show improved growth inhibition efficacy in a resistant cell culture line. The drug loaded nanoparticles were prepared using the well established emulsion polymerization process without using any modification for the hydrophilic doxorubicin drug whereas the incorporation of cyclosporin A needed to wait a moment after the polymerization reaction started. This was necessary to avoid cyclosporin A precipitation and polymer aggregation. Cyclosporin A release from the nanoparticles was rapid probably because the drug was adsorbed onto the nanoparticles surface rather than embedded into the polymeric core. Doxorubicin displayed also a burst effect but with a slower second phase probably related with the nanoparticles bioerosion rate owing to its entrapment in the polymeric network. Finally, it was shown in resistant cell culture experiments that the association of both cyclosporin A and doxorubicin within a single nanoparticle formulation elicited the most effective growth rate inhibition as compared to other combinations of both drugs while using a lower amount of polymer compared to separated nanoparticle formulations. This result was probably due to the synergistic effect achieved by combining the chemo-sensitizing compound cyclosporin A, with an effective cytotoxic drug like doxorubicin.
This paper references
10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
T. Mosmann (1983)
10.1002/(SICI)1097-0215(19970529)71:5<900::AID-IJC32>3.0.CO;2-8
Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug‐resistant cells
G. Toffoli (1997)
10.1097/00007890-199403270-00027
THE INCREASED EFFICACY AND DECREASED NEPHROTOXICITY OF A CYCLOSPORINE LIPOSOME1,2
C. Freise (1994)
10.2165/00003088-198611020-00002
Clinical Pharmacokinetics of Cyclosporin
R. Ptachcinski (1986)
10.1089/SCT.1989.5.1
Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases.
N. Chiannilkulchai (1989)
10.1038/sj.leu.2401035
The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia
M. D. Boer (1998)
10.1016/0378-5173(93)90369-Q
Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A
A. Sánchez (1993)
10.3109/02652049709006828
Stability of cyclosporine-loaded poly-X-caprolactone nanoparticles
J. Molpeceres (1997)
10.1023/A:1016366022712
Molecular Weights of Free and Drug-Loaded Nanoparticles
Luc Vansnick (2004)
10.2165/00003088-199324060-00004
Cyclosporin Clinical Pharmacokinetics
A. Fahr (1993)
The reversal of multidrug resistance in cancer (review).
Kellen Ja (1993)
10.3109/02652049109021233
Association of cyclosporin to isohexylcyanoacrylate nanospheres and subsequent release in human plasma in vitro.
S. Bonduelle (1992)
Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.
R. Maia (1997)
10.1002/JPS.2600820513
Formation and characterization of cyclosporine-loaded nanoparticles.
M. Guzmán (1993)
10.1016/0006-2952(92)90443-M
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
C. Cuvier (1992)
10.1038/bjc.1997.362
Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
A. C. de Verdière (1997)



This paper is referenced by
10.1016/j.ijpharm.2012.01.020
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Jinghua Duan (2012)
10.3390/polym11040630
Delivering Combination Chemotherapies and Targeting Oncogenic Pathways via Polymeric Drug Delivery Systems
P. Nair (2019)
10.1002/mabi.201600292
Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.
Y. Wang (2017)
10.1016/j.actbio.2009.01.026
Physicochemical characterization and in vitro behavior of daunorubicin-loaded poly(butylcyanoacrylate) nanoparticles.
Margarita Simeonova (2009)
10.1002/JPS.20100
Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers.
H. L. Wong (2004)
10.1016/J.CARBPOL.2006.11.023
Interactions between N-succinyl-chitosan and bovine serum albumin
A. Zhu (2007)
10.1016/B978-0-12-385089-8.00005-4
Targeted Drug Delivery
Zoraida P. Aguilar (2013)
10.1016/j.biomaterials.2015.01.014
Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles.
B. Xiao (2015)
10.1007/s11095-006-0282-x
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)
10.1016/J.NANO.2006.04.009
Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.
C. Reis (2006)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.1016/j.jconrel.2009.01.021
Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Y. Patil (2009)
10.1002/mabi.201200085
Cellular interactions of a water-soluble supramolecular polymer complex of carbon nanotubes with human epithelial colorectal adenocarcinoma cells.
Yeonju Lee (2012)
10.1016/j.jconrel.2018.08.013
A facile route to heterotelechelic polymer prodrug nanoparticles for imaging, drug delivery and combination therapy
Daniele Vinciguerra (2018)
10.1211/0022357011776126
Triton‐X‐100‐modified polymer and microspheres for reversal of multidrug resistance
Z. Liu (2001)
10.2217/nnm.11.48
Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma.
J. Kanwar (2011)
10.1080/10601320600575249
Investigation of Water Uptake Behavior and Mechanical Properties of Superporous Hydrogels
S. Bajpai (2006)
10.2147/IJN.S2714
Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells
B. Chen (2008)
10.1517/17425247.2011.547470
Drug delivery systems for differential release in combination therapy
Hongbin Zhang (2011)
N anoparticles in cancer therapy and diagnosis
I. Brigger (2002)
10.3389/fphar.2013.00134
Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
João Conde (2013)
10.2147/IJN.S5393
The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells
Zhi Jiang (2009)
Dendrimer-based Report-Eradication Antineoplasic Machines
Pedro Manuel Barbosa Mota (2018)
10.1002/wnan.1343
Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
Jasmine Miller-Kleinhenz (2015)
10.1016/J.EJPS.2007.04.007
Mechanistic evaluation of factors affecting compound loading into ion-exchange fibers.
Kaisa R Hänninen (2007)
10.1016/j.ejpb.2008.08.017
Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
Ayman Khdair (2009)
10.1007/s12272-013-0276-2
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
Golam Kibria (2014)
10.1039/c8tx00087e
Bioactive nano-metal-organic frameworks as antimicrobials against Gram-positive and Gram-negative bacteria.
Neha Bhardwaj (2018)
10.2217/17469600.1.1.49
Nanotechnology-based delivery systems in HIV/AIDS therapy
Aliasgar Shahiwala (2007)
Nanostrategies in the war against multidrug resistance in leukemia
Alphy Rose-James (2013)
10.1039/C2JM34853E
A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo
Uuriintuya Dembereldorj (2012)
10.1007/978-1-4419-0131-6_7
Polymeric Carriers for Anticancer Drugs
D. Kim (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar